This study showed that treatment with irinotecan and supportive care alone , compared with supportive care , prolonged the life of patients with metastatic colorectal cancer .
The trial we report was started in 1995 to compare irinotecan with supportive care alone for survival , quality  of life , and other clinical variables .
